Cargando…

An Omics View of Emery–Dreifuss Muscular Dystrophy

Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more...

Descripción completa

Detalles Bibliográficos
Autores principales: Vignier, Nicolas, Muchir, Antoine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354601/
https://www.ncbi.nlm.nih.gov/pubmed/32549253
http://dx.doi.org/10.3390/jpm10020050
_version_ 1783558122774724608
author Vignier, Nicolas
Muchir, Antoine
author_facet Vignier, Nicolas
Muchir, Antoine
author_sort Vignier, Nicolas
collection PubMed
description Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy.
format Online
Article
Text
id pubmed-7354601
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-73546012020-07-23 An Omics View of Emery–Dreifuss Muscular Dystrophy Vignier, Nicolas Muchir, Antoine J Pers Med Review Recent progress in Omics technologies has started to empower personalized healthcare development at a thorough biomolecular level. Omics have subsidized medical breakthroughs that have started to enter clinical proceedings. The use of this scientific know-how has surfaced as a way to provide a more far-reaching view of the biological mechanisms behind diseases. This review will focus on the discoveries made using Omics and the utility of these approaches for Emery–Dreifuss muscular dystrophy. MDPI 2020-06-15 /pmc/articles/PMC7354601/ /pubmed/32549253 http://dx.doi.org/10.3390/jpm10020050 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Vignier, Nicolas
Muchir, Antoine
An Omics View of Emery–Dreifuss Muscular Dystrophy
title An Omics View of Emery–Dreifuss Muscular Dystrophy
title_full An Omics View of Emery–Dreifuss Muscular Dystrophy
title_fullStr An Omics View of Emery–Dreifuss Muscular Dystrophy
title_full_unstemmed An Omics View of Emery–Dreifuss Muscular Dystrophy
title_short An Omics View of Emery–Dreifuss Muscular Dystrophy
title_sort omics view of emery–dreifuss muscular dystrophy
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354601/
https://www.ncbi.nlm.nih.gov/pubmed/32549253
http://dx.doi.org/10.3390/jpm10020050
work_keys_str_mv AT vigniernicolas anomicsviewofemerydreifussmusculardystrophy
AT muchirantoine anomicsviewofemerydreifussmusculardystrophy
AT vigniernicolas omicsviewofemerydreifussmusculardystrophy
AT muchirantoine omicsviewofemerydreifussmusculardystrophy